,PD-L1

Kaimin Xiao1, Silin Zhang2, Qi Peng1

  • 1State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China; Joint Graduate Program of Peking-Tsinghua-NIBS, School of Life Sciences, Tsinghua University, Beijing 100084, China.

Cell reports
|October 18, 2024
PubMed
概括

在树突细胞 (DC) 上编程的死亡配体1 (PD-L1) 对于有效的化疗免疫治疗至关重要. 在DC上PD-L1的损失增加了它们对化疗诱导的铁亡的易感性,抑制了抗瘤免疫力并降低了治疗效率.